270 related articles for article (PubMed ID: 17168794)
1. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.
Jiang S; Lechler RI
Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
4. Foxp3 expressing regulatory T-cells in allergic disease.
Nouri-Aria KT
Adv Exp Med Biol; 2009; 665():180-94. PubMed ID: 20429425
[TBL] [Abstract][Full Text] [Related]
5. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
Jiang S; Tsang J; Lechler RI
Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
[TBL] [Abstract][Full Text] [Related]
6. CD4+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo.
Zwar TD; Read S; van Driel IR; Gleeson PA
J Immunol; 2006 Feb; 176(3):1609-17. PubMed ID: 16424190
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.
van Herwijnen MJ; van der Zee R; van Eden W; Broere F
PLoS One; 2015; 10(6):e0128373. PubMed ID: 26107957
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cell immunotherapy for transplantation tolerance: step into clinic.
Jiang S; Tsang J; Tam P
Int Immunopharmacol; 2010 Dec; 10(12):1486-90. PubMed ID: 20736096
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells in kidney disease and transplantation.
Hu M; Wang YM; Wang Y; Zhang GY; Zheng G; Yi S; O'Connell PJ; Harris DC; Alexander SI
Kidney Int; 2016 Sep; 90(3):502-14. PubMed ID: 27263492
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
[TBL] [Abstract][Full Text] [Related]
11. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.
Johnson BA; Baban B; Mellor AL
Immunotherapy; 2009 Jul; 1(4):645-61. PubMed ID: 20161103
[TBL] [Abstract][Full Text] [Related]
12. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
Janssens I; Cools N
Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
[TBL] [Abstract][Full Text] [Related]
13. Expanding Diversity and Common Goal of Regulatory T and B Cells. II: In Allergy, Malignancy, and Transplantation.
Korczak-Kowalska G; Stelmaszczyk-Emmel A; Bocian K; Kiernozek E; Drela N; Domagała-Kulawik J
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):523-535. PubMed ID: 28470464
[TBL] [Abstract][Full Text] [Related]
14. Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.
Corsini E; Oukka M; Pieters R; Kerkvliet NI; Ponce R; Germolec DR
J Immunotoxicol; 2011; 8(4):251-7. PubMed ID: 21848365
[TBL] [Abstract][Full Text] [Related]
15. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
Terry LV; Oo YH
Front Immunol; 2020; 11():565518. PubMed ID: 33072105
[TBL] [Abstract][Full Text] [Related]
16. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T-regulatory cells: toward therapy for human diseases.
Allan SE; Broady R; Gregori S; Himmel ME; Locke N; Roncarolo MG; Bacchetta R; Levings MK
Immunol Rev; 2008 Jun; 223():391-421. PubMed ID: 18613849
[TBL] [Abstract][Full Text] [Related]
18. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
[TBL] [Abstract][Full Text] [Related]
19. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
